BECAUSE EVERY TEST IS A LIFE
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Jan 2024)
What this means for you
This application is over — abandoned 15 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88854856
- Mark type
- Stylized text
- Filed
- 31 Mar 2020
- Published for opposition
- 20 Apr 2021
- Abandoned
- 15 Jan 2024
- Attorney of record
- Alexis Crawford Douglas
Goods and services
- Class 001 — Chemicals: Diagnostic assays and reagents for blood and plasma research purposes; diagnostic assays and reagents for chemical and laboratory use
- Class 005 — Pharmaceuticals: Medical diagnostic assays and reagents for testing and screening of blood and plasma
- Class 009 — Scientific and electric apparatus: Downloadable computer software and recorded computer software for use in diagnostic testing, screening, and management of blood and plasma, namely, software that allows blood and plasma information to be recorded and maintained, instruments to be monitored, and quality control to be managed; software used by laboratories in connection with immunohematology analyzers, namely, a downloadable software program and a recorded software program that assists the operator in effectively performing the required testing on the immunohematology analyzers, run via computer; computer hardware used by laboratories in connection with immunohematology analyzers that assists the operator in effectively performing the required testing on the immunohematology analyzers, run via computer
- Class 010 — Medical apparatus: Medical equipment, namely, chemistry analyzer apparatus used to generate diagnostic test results from blood and other body fluids by professionals in hospitals, laboratories, clinics and doctors' offices; Blood testing apparatus; Apparatus and medical diagnostic instruments for blood analysis; Medical diagnostic equipment and instruments, namely, immunohematology analyzer apparatus for blood screening, blood typing, detection of assays associated with blood screening and blood typing used in the transfusion medicine market
Owner
- Crimson U.S. Assets LLC, Raritan, NJ, US
- Crimson U.S. Assets LLC, Raritan, NJ, US
Prosecution history
- 16 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jun 2023 — SOU EXTENSION 4 GRANTED
- 15 Jun 2023 — SOU EXTENSION 4 FILED
- 15 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2022 — SOU EXTENSION 3 GRANTED
- 15 Dec 2022 — SOU EXTENSION 3 FILED
- 15 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 15 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2022 — SOU EXTENSION 2 GRANTED
- 13 Jun 2022 — SOU EXTENSION 2 FILED
- 13 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 14 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED